Concepedia
Statistics
Publications
5
Citations
1.1K
H-Index
Active since
2013
Affiliations
Inserm(Current)
Université Claude Bernard Lyon 1
Centre National de la Recherche Scientifique
Centre Léon Bérard
Centre de Recherche en Cancérologie de Lyon
Amélien Sanlaville is an author at Inserm specializing in t cell immunity, tumor immunity, and tumor biology.
Top concepts
MedicineImmunologyAutoimmunityCell BiologyBreast CancerImmunotherapyTumor BiologyTumor ImmunityImmuno-oncologyT Cell Immunity
Publications per year
2013–2021
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Sébastien Viel, Antoine Marçais, Fernando Guimarães et al. · Science Signaling · 2016 · 611 citations
Tumor Promotion by Intratumoral Plasmacytoid Dendritic Cells Is Reversed by TLR7 Ligand Treatment
Isabelle Le Mercier, Dominique Poujol, Amélien Sanlaville et al. · Cancer Research · 2013 · 191 citations · Full text
Tumor-associated Pdc, Immunology, Immune Regulation +20
Regulatory T cells promote cancer immune-escape through integrin αvβ8-mediated TGF-β activation
Alexandra Lainé, Ossama Labiad, Héctor Hernández‐Vargas et al. · Nature Communications · 2021 · 150 citations · Full text
Comprehensive characterization of claudin-low breast tumors reflects the impact of the cell-of-origin on cancer evolution
Roxane M. Pommier, Amélien Sanlaville, Laurie Tonon et al. · Nature Communications · 2020 · 98 citations · Full text
Type 1 conventional dendritic cells and interferons are required for spontaneous CD4 <sup>+</sup> and CD8 <sup>+</sup> T‐cell protective responses to breast cancer
Raphaël Mattiuz, Carine Brousse, Marc Ambrosini et al. · Clinical & Translational Immunology · 2021 · 54 citations · Full text
1–5 of 5